Statera Biopharma | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Mar 3, 2023 23:46
Statera Biopharma | DEFR14A: Definitive proxy statement in connection with contested solicitations
Mar 1, 2023 10:06
Statera Biopharma | DEF 14A: Definitive proxy statements
Feb 27, 2023 19:01
Statera Biopharma | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
Feb 15, 2023 22:08
Statera Biopharma | 8-K: Current report
Feb 2, 2023 05:34
Statera Biopharma | 8-A12G: Others
Feb 2, 2023 05:08
Statera Biopharma | 8-K: Current report
Jan 21, 2023 05:53
Statera Biopharma | DEF 14A: Definitive proxy statements
Nov 29, 2022 05:19
Statera Biopharma | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
Nov 18, 2022 21:02
Statera Biopharma | 8-K: Current report
Nov 15, 2022 19:04
Statera Biopharma | 10-Q: Q3 2022 Earnings Report
Nov 15, 2022 06:22
Statera Biopharma | 8-K: Current report
Nov 5, 2022 09:51
Statera Biopharma | D: Filing D
Nov 5, 2022 06:59
Statera Biopharma | 10-Q: Quarterly report
Oct 28, 2022 20:49
Statera Biopharma | 8-K: Current report
Oct 28, 2022 05:00
Statera Biopharma | 8-K: Current report
Oct 24, 2022 18:08
Statera Biopharma | 10-Q: Q1 2022 Earnings Report
Oct 21, 2022 21:00
Statera Biopharma | 8-K: Current report
Oct 18, 2022 05:30
Statera Biopharma | 10-K: FY2021 Annual Report
Oct 6, 2022 06:00
Statera Biopharma | 8-K: Current report
Sep 27, 2022 23:26
No Data
No Data